Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (488)	1/26/2000 2:14:00 PM
From: Cheryl Galt	Respond to of 1475

Experiment: At 1:26pm i put in a day order for a position at $6.75, the price of the last sale. I doubt it will fill, but if it does I'll be happy. My theory: A few people are transferring their money to the current momo biotechs, planning to get back into BTRN before it takes off. BTRN logistics: Shares out - 8.59M Float ------ 2.80M (according to Yahoo) Insiders own 67% 18 Institutions own 29% (88% of the float) With logistics like that, coupled with BTRN's science and patents, it's easy to be patient ... Cheryl PS - Just checked. No fill on that order. PPS - Just saw what a notice of Celgene's coming 4Q report did for CELG. When is BTRN's coming out?